The McTigue lab uses preclinical models to study cellular repair after spinal cord injury (SCI), including oligodendrocyte generation and myelination. More recent studies also study systemic metabolic pathology, including fatty liver disease, insulin resistance and dyslipidemia. The goal of all work is to improve the lives of those living with SCI.